JHXJames Hardie

James Hardie shares fell sharply as investors sold into positive news flow around the AZEK merger integration and a US$980m asset sale, with broader sector and market weakness adding pressure.

James Hardie lifted FY27 sales guidance due to AZEK integration and positive siding volumes.

James Hardie's share price surged after releasing strong preliminary Q1 FY2027 results, with revenue forecasted at $1.48B, beating market expectations and driving investor optimism about US housing demand recovery.

Housing-linked growth optimism returned to the sector, driving a broad rally in James Hardie shares.

James Hardie's FY26 results beat expectations, driving a strong share price rebound after an initial earnings-related selloff.

No clear cause identified; news articles are post-move commentary, not a specific trigger for the decline.

James Hardie shares fell 4.27% on April 16, 2026, amid a broader rotation out of cyclical stocks into tech shares, as highlighted by The Bull's article that day.

Downward pressure from AustralianSuper trimming its position, but a broader market rebound driven by value-seeking commentary lifted the stock.

Insufficient evidence to determine the cause of the price move.

James Hardie reported a strong FY26 Q3 result, with sales up 30% boosted by the AZEK acquisition, driving the share price up over 10%.

Insufficient evidence from news articles to determine the cause of the price move.

The rally appears coincidental with no direct supporting news; likely driven by sector flow or broader market moves on the historical date.

JHX rose 9.87% on 2025-11-17 despite a broad ASX 200 tech-led selloff, but no specific company news explains the move.

James Hardie's shares plunged following a response to an ASX price query and reports of worsening company woes, likely driven by a negative operational update or earnings miss.

The observed 9.92% price increase for James Hardie on 2025-10-07 is likely part of a broad market rally, but specific news is lacking.

The price increase appears to be a reaction to earnings, but the available news suggests a negative interpretation, making the cause unclear.

James Hardie shares rose 5.25% on 2025-08-22, likely due to a rebound after a significant earnings-driven sell-off earlier in the week, despite negative media coverage.

James Hardie shares plunged after reporting a shock full-year earnings result that fell below expectations, sparking fears of a potential capital raise.

The stock plunged 27.83% following a shocking earnings result that missed expectations, with speculation the company may be forced to raise capital.

Insufficient news coverage around the event date to identify a specific cause for the price move.

No specific catalyst identified; broad market lift on ASX 200 could have contributed, but evidence is insufficient.

The stock's upward movement appears to be linked to index rebalancing news from S&P DJI, which likely included JHX in a favorable adjustment.

James Hardie issued a warning while defending its $14b Azek deal, and a separate article said the merger makes no strategic sense, weighing on shares.

The news article about James Hardie CEO partying in Florida as shareholders seethe is not directly related to the stock's positive price movement; thus, the cause cannot be determined from the provided information.

James Hardie's expansion strategy following a major acquisition deal faced scrutiny, likely prompting investor concerns and a sell-off.

No specific cause identifiable from available news articles; the sharp decline may reflect a market-wide factor or unannounced company-specific issue.

Investor concern that the $14b Azek deal was overvalued triggered a sell-off in James Hardie shares.

Investor concerns that James Hardie's $14 billion Azek deal was overvalued drove the stock down sharply.

James Hardie reported Q2 FY25 results on 13 Nov 2024, likely beating expectations and driving the stock up.